TBTEAM overview: 2013 priorities

Dr Christian Gunneberg

TBTEAM secretariat

WHO Global TB Programme

EIGHTH NATIONAL TB PROGRAMME AND LABORATORY MANAGERS' MEETING IN THE WESTERN PACIFIC REGION

Manila, Philippines 20-23 August 2013

TBTEAM review TB TEchnical Assistance Mechanism

I will talk about: Progress since 2012: News from the Website Strategic planning and reviews Progress on Global Fund grants. Raise it: spend it: prove it. 2013 priorities Global Fund grant monitoring and support 42 priority countries of the USAID grant.

TBTEAM Website Completed mission, and uploaded mission report trend

0

100

200

300

400

500

600

700

800

900

2009(6%)

2010(11%)

2011(13%)

2012(23%)

Missions with report uploaded mission without report

793 780

680 706

Where is the TA being provided?

TB Technical Partners missions by Region TBTEchnical Assistance Mechanism

2009 2010 2011 2012

AMRO 82 58 49 40

EMRO 92 106 55 57

WPRO 112 140 139 92

SEARO 106 101 79 100

EURO 190 135 128 125

AFRO 211 240 230 292

0

100

200

300

400

500

600

700

800

900

Nu

mb

er

of

mis

sio

ns

REGIONS 2012

AMR 6%

EMR 8%

WPR 13%

SEAR 14%

EUR 18%

AFR 41%

WHO is organising

the TA?

Proportion of Missions organised by TBTEAM Partner Organisations 2012

From the TBTEAM website

WHO 40%

KNCV 20%

CDC 9%

The Union 8%

GDF 7%

TBREACH 3%

GLI 2% Damien

Foundation 2%

PATH 2%

National TBTEAM

2%

Supranational Reference Laboratory (Milan, Italy)

2%

NTP 1%

Management Sciences for Health

1%

Grant Management Solutions Project (GMS)

1%

TeAM 1% Project Hope

1%

Other 7%

WHO/ HQ 18%WHO/CO 6%WHO/SEARO 4%WHO/EMRO 4%WHO/EURO 3%WHO/WPRO 2%WHO/AMRO 2%WHO/AFRO 1%

WHAT

type of TA

Is being organised?

Top 10?

TA missions by Primary Purpose Top ten areas of TA

make up 80% of missions

RANK TA SUPPORT AREA 2012 % Cum

1 Laboratory strengthening 90 12.7% 12.7%

2 MDR-TB / XDR-TB 82 11.6% 24.4%

3 M&E/supervision/ impact measurement 80 11.3% 35.7%

4 Drug and commodities management 68 9.6% 45.3%

5 TB programme planning and review / regional meetings 66 9.3% 54.7%

6 Global Fund Processes/ proposal implementation/Grant negociation 64 9.1% 63.7%

7 Infection control 36 5.1% 68.8%

8 Operational and basic science research 34 4.8% 73.7%

9 TB/HIV 24 3.4% 77.1%

10 ACSM 21 3.0% 80.0%

11 Childhood TB 17 2.4%

12 Human Resources Development 13 1.8%

13 PPM, ISTC 11 1.6%

14 High risk groups: prisoners, refugees, TB contacts, special 10 1.4%

15 Drug Resistance Surveillance (DRS) 9 1.3%

16 Community-based activities for improved TB prevention, diagnosis 9 1.3%

17 PAL 8 1.1%

18 Partnering 5 0.7%

19 X-ray, other non-laboratory diagnostics 2 0.3%

20 Cross-cutting Health System Strengthening 2 0.3%

21 Other 55 7.8%

TOTAL 706 100% 100%

TBTEAM 2013 priorities

Objective 1

To coordinate the provision of quality TA and programme reviews that inform Global Fund periodic reviews (Phase 2 renewals) and grant implementation in 42 priority countries and countries with poorly performing grants.

Objective 2:

To strengthen the capacity of National TB Programs (NTPs) and TB stakeholders at country level to engage with Global Fund grant processes, including the development and improvement of National Strategic Plans and coordination of TA among technical partners.

42 Priority countries for Global Fund (USAID GRANT)

And any additional poorly performing grants

Now includes South Africa

Countries

Afghanistan DR Congo Kenya Pakistan Ukraine

Azerbaijan Ethiopia Kyrgyzstan Philippines Uzbekistan

Bangladesh Georgia Madagascar Rwanda Vietnam

Belarus Ghana Malawi Sierra Leone Zambia

Burkina Faso Guinea Moldova Somalia Zimbabwe

Burundi Haiti Mozambique South Sudan

Cambodia India Myanmar Tajikistan

Central African

Republic

Indonesia Nepal Tanzania

Chad Kazakhstan Nigeria Uganda

3 Countries in WPR

TBTEAM priorities 2013

• Regional trainings and workshops for country stakeholders.

• Assistance with development of National Strategic Plans

• Assistance with the development of concept notes.

• TBTEAM website development

• The need for Advocacy

TBTEAM 2013 priorities

• Tracking Grant Performance • Regular engagement with Global Fund country teams .

(And linking these to partners when necessary)

• TB technical knowledge sharing with Fund Portfolio Managers

• Support for the New Funding Model – Including consultant training (9th to 11th July)

• Support to Phase 2 /periodic reviews – Pre-CCM Performance Assessment – Stakeholder Coordination and Determining TA Needs – CCM Applications – Pre-renewal preparations and post-renewal follow up

Regional TBTEAM workshops on

Strategic planning

Organizing Regional workshops (68 countries) • review of key principles in order to establish an appropriate NSP.

• Peer critique of existing country NSPs

• simulation exercises TUBERCOLAND with SWOT analysis, M&E , Operational, TA Plans

• Roadmaps and follow up on development, revision or improvement of NSPs for TB control

Eastern Mediterranean (December 2011) 9 countries

South East Asia (May 2012), 11 countries

Europe (October, 2012) 16 countries

Africa (October 2012) 27 countries Western Pacific Region (January 2013) 5 countries

These 68 countries already sensitised hold over 70% of Global Burden of TB

KEY MESSAGE

• Partners need to play a crucial role in supporting implementation of Global Fund grants locally and linking the local TB stakeholders locally and to TBTEAM partners (esp. USAID/WHO) globally.

• A focal point helps this process locally. (Eg TBCARE)

" Thank goodness, since the Global Fund Grant is stuck, we've been able to implement our programme"

Discussion: grant stakeholders and engagement

• What topics should be covered with each stakeholder?

• What frequency of interactions is appropriate? Why?

CT

CCM

PR

Govern-ment

Other donor

s LFA

Donors

Tech-nical

CSOs

NGOs

MoF

MoH

MoJ

SSR

SR

Partners

THE TBTEAM hardware for inclusion in grant discussions

includes WHO Regional Offices: overall & reviews

WHO country staff (engagement) TBCARE in country/global USAID TB advisors/global

Other TBTEAM partners, (including consultants) TME If Prevalence Survey/ or IMPACT wk

GDF Drugs MDR – GLC issues

Laboratory- GLI / Expand TB Engage TB

Civil Society Activists TB/HIV

PPP Operational Research

TABLE 2

Latest Grant Performance Score

Global Fund Grants A1 / A2 B1 B2 C

HIV/AIDS (191 grants) 40% 38% 19% 3%

Malaria (117 grants) 28% 32% 25% 15%

Other (7 grants) 14% 57% 14% 14%

Tuberculosis (130 grants) 38% 49% 12% 0%

Tuberculosis GF grant performance by Region (data end of 2012)

The 46% of 125 TB grants with A1&A2 ratings masks regional variations. The 38 TB grants in Africa only have 26% with A1 A2 ratings, In WPRO only 3 of the 10 grants have A1& A2 ratings.